India’s Pharma Sales Growth Slows In Lockdown-Marred March
Capsules are laid out for inspection on the production line of a drug factory. (Photographer: Tomohiro Ohsumi/Bloomberg)

India’s Pharma Sales Growth Slows In Lockdown-Marred March

India’s pharmaceutical sales rose in March, albeit at a sluggish pace, owing to panic buying of medicines for chronic ailments such as cardiac and diabetes amid a nationwide lockdown to combat the ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.